Sumeer Dhar Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

1/2004

Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumeer Dhar Research Topics

Disease

2	Neoplasms (Cancer) 01/2004 - 09/2003
1	Carcinoma (Carcinomatosis) 06/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2002

Drug/Important Bio-Agent (IBA)

1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2006
1	dicyandiamido (cyanoguanidine)IBA 01/2004
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2004
1	metamelfalanIBA 09/2003
1	OligopeptidesIBA 09/2003
1	PeptichemioIBA 09/2003
1	Amino Acids FDA Link 09/2003
1	flupirtineIBA 04/2002